Blood-Based Biomarkers May Parallel Progression Of Alzheimer’s Disease Neurodegeneration, Researchers Say

January 13, 2021

MedPage Today (1/12, George) reports, “Blood-based biomarkers paralleled the progression of Alzheimer’s disease neurodegeneration,” investigators concluded in “a large longitudinal cohort study.” The study revealed that “increases of phosphorylated tau at...